By InvitationNot Applicable

Technology-Based Resources to Increase Uptake of Sexual Health Services for Teens

United States60 participantsStarted 2023-03-01

Plain-language summary

Alone time with healthcare providers is vital for adolescents, as recommended by several professional organizations, as it enhances health service utilization, empowers adolescents to manage their health, and facilitates discussions on sensitive issues. Despite its importance, only 40% of adolescents have private conversations with clinicians during visits. mHealth technology offers a promising solution for effective interventions to promote alone time with providers for adolescents, parents, and healthcare providers. This pilot study aims to evaluate the preliminary efficacy of a technology-based intervention designed to increase alone time with providers during well-adolescent visits (WAVs) and its impact on trustworthiness, parent-adolescent communication, sexual risk communication, parental monitoring, and parental support. After providing consent, participants accessed a study website to complete a baseline survey, interact with four modules, and complete a post-test survey one month after WAVs. Surveys assessed alone time, trustworthiness, parent-adolescent communication, sexual risk communication, parental monitoring, and parental support.

Who can participate

Age range

11 Years – 17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The child is between 11 and 17 years old * The child can read and speak English * The child has access to the internet (via phone or computer) * The child has a well-child visit scheduled in the next 6 months. * Mother could be included if they had an adolescent enrolled in this study * Mother who speaks and reads English, Cantonese, Mandarin, or Spanish * Mother has access to the internet. Exclusion Criteria: * Not have a well-child visit scheduled in the next 6 months.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Young Adult Health Care Survey (YAHCS) for Alone time

Timeframe: From enrollment to the end of intervention at 6 months

Trial details

NCT IDNCT07064070

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-30

View on ClinicalTrials.gov More mHealth Intervention trials